SILVERMAN, G. J., & PELZEK, A. (2014). Rheumatoid Arthritis Clinical Benefits from Abatacept, Cytokine Blockers, and Rituximab Are All Linked to Modulation of Memory B Cell Responses. J Rheumatol.
Chicago Style CitationSILVERMAN, GREGG J., i ADAM PELZEK. "Rheumatoid Arthritis Clinical Benefits From Abatacept, Cytokine Blockers, and Rituximab Are All Linked to Modulation of Memory B Cell Responses." J Rheumatol 2014.
Cita MLASILVERMAN, GREGG J., i ADAM PELZEK. "Rheumatoid Arthritis Clinical Benefits From Abatacept, Cytokine Blockers, and Rituximab Are All Linked to Modulation of Memory B Cell Responses." J Rheumatol 2014.
Atenció: Aquestes cites poden no estar 100% correctes.